Last update: Jan. 15, 2019
Not risky for breastfeeding or infant.
An antihypertensive vasodilator used in the form of a 2%-5% topical solution in androgenetic alopecia.
The small dose and low plasma absorption of most topical dermatological preparations make transfer in significant amounts into breastmilk very unlikely.
Only 1.4% (0.3-4.5%) of minoxidil reaches blood plasma when it is used topically on the skin (Butler 2014, Johnson 2014, Galderma 2013).
Minoxidil taken orally is excreted in breastmilk in clinically insignificant amounts and no problems have been observed in an infant whose mother was taking it (Valdivieso 1985).
It is normal to lose hair in the months following pregnancy and this has nothing to do with breastfeeding but with stopping the resting phase in hair loss that occurs during pregnancy. Within 12 months after delivery, the hair grows back without leaving alopecia.
American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001).
We do not have alternatives for Minoxidil topical use since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Instituto de Salud Infantil, Grecia-Institute of Child's Health in Greece
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM